In vitro evaluation of oestrogenic/androgenic activity of the serum organochlorine pesticide mixtures previously described in a breast cancer case-control study

Science of the Total Environment

Volumn 537, Issue , 2015, Pages 197-202

  Rivero, Javier ^a   Luzardo, Octavio P ^a   Henríquez Hernández, Luis A ^a   Machín, Rubén P ^a   Pestano, José ^a   Zumbado, Manuel ^a   Boada, Luis D ^a   Camacho, María ^a   Valerón, Pilar F ^a  

^a UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

Author keywords

Cyclodienes; DDT; Endocrine disruption; Human breast cancer cells; Pesticide mixtures; POPs

Indexed keywords

BODY FLUIDS; CELL PROLIFERATION; CELLS; CYTOLOGY; DISEASES; PESTICIDES;

CYCLODIENES; DDT; ENDOCRINE DISRUPTION; HUMAN BREAST CANCER CELLS; PESTICIDE MIXTURE; POPS;

MIXTURES;

ESTRADIOL; ESTROGEN RECEPTOR; ORGANOCHLORINE PESTICIDE; ANDROGEN; CHLORINATED HYDROCARBON; ESTROGEN; PESTICIDE;

CANCER; CARCINOGEN; DDT; ENDOCRINE DISRUPTOR; ESTROGENIC COMPOUND; ORGANOCHLORINE PESTICIDE; SERUM;

ANDROGENIC ACTIVITY; ARTICLE; BREAST CANCER CELL LINE; CASE CONTROL STUDY; CELL ASSAY; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; ESTROGENIC ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; MCF 7 CELL LINE; MDA MB 231 CELL LINE; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; PRIORITY JOURNAL; SPAIN; ADULT; BLOOD; BREAST TUMOR; ENVIRONMENTAL EXPOSURE; STATISTICS AND NUMERICAL DATA;

SPAIN;

ADULT; ANDROGENS; BREAST NEOPLASMS; ENVIRONMENTAL EXPOSURE; ESTROGENS; FEMALE; HUMANS; HYDROCARBONS, CHLORINATED; PESTICIDES; SPAIN;

EID: 84941272101     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2015.08.016     Document Type: Article

References (36)

1. Almeida-González M., Luzardo O.P., Zumbado M., Rodríguez-Hernández A., Ruiz-Suárez N., Sangil M., et al. Levels of organochlorine contaminants in organic and conventional cheeses and their impact on the health of consumers: an independent study in the Canary Islands (Spain). Food Chem. Toxicol. 2012, 50:4325-4332.
2. Andersson S., Krogstad J.M., Finset A. Apathy and depressed mood in acquired brain damage: relationship to lesion localization and psychophysiological reactivity. Psychol. Med. 1999, 29:447-456.
3. Arrebola J.P., Belhassen H., Artacho-Cordon F., Ghali R., Ghorbel H., Boussen H., et al. Risk of female breast cancer and serum concentrations of organochlorine pesticides and polychlorinated biphenyls: a case-control study in Tunisia. Sci. Total Environ. 2015, 520:106-113.
4. Aube M., Larochelle C., Ayotte P. 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (p, p'-DDE) disrupts the estrogen-androgen balance regulating the growth of hormone-dependent breast cancer cells. Breast Cancer Res. 2008, 10:R16.
5. Aube M., Larochelle C., Ayotte P. Differential effects of a complex organochlorine mixture on the proliferation of breast cancer cell lines. Environ. Res. 2011, 111:337-347.
6. Boada L.D., Zumbado M., Henriquez-Hernandez L.A., Almeida-Gonzalez M., Alvarez-Leon E.E., Serra-Majem L., et al. Complex organochlorine pesticide mixtures as determinant factor for breast cancer risk: a population-based case-control study in the Canary Islands (Spain). Environ. Health 2012, 11:28.
7. Boada L.D., Sangil M., Álvarez-León E.E., Hernández-Rodríguez G., Henríquez-Hernández L.A., Camacho M., et al. Consumption of foods of animal origin as determinant of contamination by organochlorine pesticides and polychlorobiphenyls: results from a population-based study in Spain. Chemosphere 2014, 114:121-128.
8. Cabanes A., Vidal E., Perez-Gomez B., Aragones N., Lopez-Abente G., Pollan M. Age-specific breast, uterine and ovarian cancer mortality trends in Spain: changes from 1980 to 2006. Cancer Epidemiol. 2009, 33:169-175.
9. Colborn T., vom Saal F.S., Soto A.M. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ. Health Perspect. 1993, 101:378-384.
10. Coss C.C., Jones A., Dalton J.T. Selective androgen receptor modulators as improved androgen therapy for advanced breast cancer. Steroids 2014, 90:94-100.
11. Fucic A., Gamulin M., Ferencic Z., Katic J., Krayer von Krauss M., Bartonova A., et al. Environmental exposure to xenoestrogens and oestrogen related cancers: reproductive system, breast, lung, kidney, pancreas, and brain. Environ. Health 2012, 11(Suppl. 1):S8.
12. Gray L.E., Wilson V.S., Stoker T., Lambright C., Furr J., Noriega N., et al. Adverse effects of environmental antiandrogens and androgens on reproductive development in mammals. Int. J. Androl. 2006, 29:96-104. (discussion 105-8).
13. Jaga K., Dharmani C. Global surveillance of DDT and DDE levels in human tissues. Int. J. Occup. Med. Environ. Health 2003, 16:7-20.
14. Kortenkamp A., Scholze M., Ermler S. Mind the gap: can we explain declining male reproductive health with known antiandrogens?. Reproduction 2014, 147:515-527.
15. Kurebayashi J., Otsuki T., Kunisue H., Tanaka K., Yamamoto S., Sonoo H. Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer. Clin. Cancer Res. 2000, 6:512-518.
16. Lacroix M., Toillon R.A., Leclercq G. p53 and breast cancer, an update. Endocr. Relat. Cancer 2006, 13:293-325.
17. Lopez-Abente G., Pollan M., Aragones N., Perez Gomez B., Hernandez Barrera V., Lope V., et al. State of cancer in Spain: incidence. An. Sist. Sanit. Navar. 2004, 27:165-173.
18. Lopez-Cervantes M., Torres-Sanchez L., Tobias A., Lopez-Carrillo L. Dichlorodiphenyldichloroethane burden and breast cancer risk: a meta-analysis of the epidemiologic evidence. Environ. Health Perspect. 2004, 112:207-214.
19. Luzardo O.P., Mahtani V., Troyano J.M., Alvarez de la Rosa M., Padilla-Perez A.I., Zumbado M., et al. Determinants of organochlorine levels detectable in the amniotic fluid of women from Tenerife Island (Canary Islands, Spain). Environ. Res. 2009, 109:607-613.
20. Luzardo O.P., Boada L.D., Carranza C., Ruiz-Suárez N., Henríquez-Hernández L.A., Valerón P.F., et al. Socioeconomic development as a determinant of the levels of organochlorine pesticides and PCBs in the inhabitants of Western and Central African countries. Sci. Total Environ. 2014, 497-498:97-105.
21. Maness S.C., McDonnell D.P., Gaido K.W. Inhibition of androgen receptor-dependent transcriptional activity by DDT isomers and methoxychlor in HepG2 human hepatoma cells. Toxicol. Appl. Pharmacol. 1998, 151:135-142.
22. Maruthappu M., Watkins J.A., Waqar M., Williams C., Ali R., Atun R., et al. Unemployment, public-sector health-care spending and breast cancer mortality in the European Union: 1990-2009. Eur. J. Public Health 2015, 25(2):330-335.
23. Missmer S.A., Eliassen A.H., Barbieri R.L., Hankinson S.E. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J. Natl. Cancer Inst. 2004, 96:1856-1865.
24. Mustonen M.V., Pyrhonen S., Kellokumpu-Lehtinen P.L. Toremifene in the treatment of breast cancer. World J. Clin. Oncol. 2014, 5:393-405.
25. Nuttall M.E., Pendrak I., Emery J.G., Nadeau D.P., Fisher P.W., Nicholson T.A., et al. Antagonism of oestrogen action in human breast and endometrial cells in vitro: potential novel antitumour agents. Cancer Chemother. Pharmacol. 2001, 47:437-443.
26. Ortmann J., Prifti S., Bohlmann M.K., Rehberger-Schneider S., Strowitzki T., Rabe T. Testosterone and 5 alpha-dihydrotestosterone inhibit in vitro growth of human breast cancer cell lines. Gynecol. Endocrinol. 2002, 16:113-120.
27. Robertson J.F. Faslodex (ICI 182, 780), a novel estrogen receptor downregulator-future possibilities in breast cancer. J. Steroid Biochem. Mol. Biol. 2001, 79:209-212.
28. Schiliro T., Porfido A., Spina F., Varese G.C., Gilli G. Oestrogenic activity of a textile industrial wastewater treatment plant effluent evaluated by the E-screen test and MELN gene-reporter luciferase assay. Sci. Total Environ. 2012, 432:389-395.
29. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 1990, 82:1107-1112.
30. Snedeker S.M. Pesticides and breast cancer risk: a review of DDT, DDE, and dieldrin. Environ. Health Perspect. 2001, 109(Suppl. 1):35-47.
31. Szelei J., Jimenez J., Soto A.M., Luizzi M.F., Sonnenschein C. Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor. Endocrinology 1997, 138:1406-1412.
32. Valeron P.F., Pestano J.J., Luzardo O.P., Zumbado M.L., Almeida M., Boada L.D. Differential effects exerted on human mammary epithelial cells by environmentally relevant organochlorine pesticides either individually or in combination. Chem. Biol. Interact. 2009, 180:485-491.
33. WHO Global Assessment of the State-of-the-Science of Endocrine Disruptors 2002.
34. Wilson V.S., Blystone C.R., Hotchkiss A.K., Rider C.V., Gray L.E. Diverse mechanisms of anti-androgen action: impact on male rat reproductive tract development. Int. J. Androl. 2008, 31:178-187.
35. Wolff M.S., Zeleniuch-Jacquotte A., Dubin N., Toniolo P. Risk of breast cancer and organochlorine exposure. Cancer Epidemiol. Biomarkers Prev. 2000, 9:271-277.
36. Zumbado M., Goethals M., Alvarez-Leon E.E., Luzardo O.P., Cabrera F., Serra-Majem L., et al. Inadvertent exposure to organochlorine pesticides DDT and derivatives in people from the Canary Islands (Spain). Sci. Total Environ. 2005, 339:49-62.